Skip to content

Clinical trials

Lung Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Country / region: Germany Clear all

205 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20003
20015
20021
20034
20043
20055
20069
20076
20082
20099
20109
20119
20125
20136
201412
20159
201611
201710
20184
20194
20205
20219
20228
20239
202415
202513
202611

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed105
Recruiting41
Active, not recruiting24
Terminated19
Unknown status11
Withdrawn3
Not yet recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals14
Eli Lilly and Company11
European Organisation for Research and Treatment of Cancer - EORTC11
AstraZeneca10
Bristol-Myers Squibb10
Pfizer7
Amgen6
University Hospital, Essen6
Hoffmann-La Roche5
Merck Sharp & Dohme LLC5

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms205
Carcinoma, Non-Small-Cell Lung103
Neoplasms24
Breast Neoplasms19
Lung Diseases16
Carcinoma15
Colorectal Neoplasms15
Neoplasm Metastasis14
Ovarian Neoplasms13
Pancreatic Neoplasms12

Trials

Showing 76 to 100 of 205. Each trial links to its page on Pharma Observatory.

105 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.